Joint Campus Placement Drive of Sun Pharmaceutical Industries Limited for M.Sc. Chemistry/Biotechnology Batch 2017-19, B.Pharma Batch 2015-19, D.Pharma Batch 2016-19 & B.Sc. Batch 2016-19 Candidates in Maharaja Agrasen University on 17 March 2019 Sunday.

Joint Campus Placement Drive of Sun Pharmaceutical Industries Limited for M.Sc. Chemistry/Biotechnology Batch 2017-19, B.Pharma Batch 2015-19, D.Pharma Batch 2016-19 & B.Sc. Batch 2016-19 Candidates in Maharaja Agrasen University on 17 March 2019 Sunday.


Name of the Company

Sun Pharmaceutical Industries Limited 

Date of Placement

17 March 2019 Sunday

Profile of the Company

Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA, BSE: 524715) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances. In 2011, Sun Pharma entered into a joint venture with MSD to bring complex or differentiated generics to emerging markets (other than India).


In 2012, Sun announced acquisitions of two US companies: DUSA Pharmaceuticals, a dermatology device company; and generic pharmacompany URL Pharma.  In 2013, the company announced an R&D joint venture for ophthalmology with the research company, Intrexon.

On 6 April 2014, Sun Pharma announced that it would acquire 100% of Ranbaxy Laboratories Ltd, in an all-stock transaction, valued at $4 billion. Japan's Daiichi Sankyo held 63.4% stake in Ranbaxy. After this acquisition, Sun Pharma has become the largest pharmaceutical company in India, the largest Indian Pharma company in US, and the 5th largest generic company worldwide.


In December 2014, the Competition Commission of India approved SunPharma's $3.2 billion bid to buy Ranbaxy Laboratories, but ordered the firms to divest seven products to ensure the deal doesn't harm competition. In March 2015, Sun Pharma announced it had agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.



Eligibility Criteria

M.Sc. Chemistry Batch 2017-19

M.Sc. Biotechnology Batch 2017-19

B.Pharma Batch 2015-19

B.Sc. Batch 2016-19

D.Pharma Batch 2017-19, 2016-18


Between Rs. 1.20 LPA to Rs. 1.80 LPA depending upon candidate.

Location of Job

Paonta Sahib, Distt. Sirmour, Himachal Pradesh.


Life science Chemist/ Manufacturing Assistant

Selection Process

·     Pre Placement Talk

·     Personal Interview

·     HR Interview

Venue of Placement

Placement Cell, A-107, Block A, Maharaja Agrasen University

Atal Shiksha Kunj, Kalujhanda, Near Barotiwala, Tehsil Baddi Distt. Solan , Himachal Pradesh.  (30 Kms from Chandigarh)

Helpline : 7832929211

Pre Registration with T&P Cell is mandatory for participation

Last date of registration on link below is 16 March, 2019 (Saturday) before 04:00 PM

Important Instructions

Reporting Time: 9:30 AM

Lunch time will be from 1:00 PM to 1:30 PM.

The selection process is a single day process and final selections will be declared by the evening.

Students should be in formal dress.

Mandatory Documents during Placement Drive

Latest Copy of Resume / CV

Two Latest Color Passport Size Photographs